Zobrazeno 1 - 10
of 60
pro vyhledávání: '"PegIFNα-2b"'
Autor:
Chen, Jun1,2 (AUTHOR), Qi, Min1 (AUTHOR), Fan, Xue-Gong1,2 (AUTHOR), Hu, Xing-Wang1,2 (AUTHOR), Liao, Cheng-Jin1 (AUTHOR), Long, Li-Yuan1 (AUTHOR), Zhao, Xiao-Ting1 (AUTHOR), Tan, Min1 (AUTHOR), Li, Hai-Fu1 (AUTHOR), Chen, Ruo-Chan1,2 (AUTHOR), Huang, Ze-Bing1,2 (AUTHOR) 36165934@qq.com, Huang, Yan1,2 (AUTHOR) drhyan@126.com
Publikováno v:
Infectious Diseases & Therapy. Dec2021, Vol. 10 Issue 4, p2259-2270. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Scientific Reports
Scientific Reports
Patients with low hepatitis B surface antigen (HBsAg) levels and hepatitis B virus (HBV) DNA suppression by nucleos(t)ide analogues (NAs) achieve high rate of HBsAg loss through switching to PegIFNα in pre-registration study. The aim of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4854d461fb0f36972583842c447c1965
http://link.springer.com/article/10.1038/s41598-017-13747-9
http://link.springer.com/article/10.1038/s41598-017-13747-9
Autor:
Min Qi, Min Tan, Yan Huang, Hai-Fu Li, Jun Chen, Xiao-Ting Zhao, Li-Yuan Long, Xingwang Hu, Xue-Gong Fan, Ruochan Chen, Ze-Bing Huang, Cheng-Jin Liao
Publikováno v:
Infectious Diseases and Therapy
Introduction Hepatitis B surface antigen (HBsAg) clearance is the treatment goal for hepatitis B e antigen (HBeAg)-negative patients with chronic hepatitis B (CHB). However, its rate is extremely low with nucleoside (acid) analogues (NAs) monotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68c979646cbfae642af311378226432
https://doi.org/10.1007/s40121-021-00497-5
https://doi.org/10.1007/s40121-021-00497-5
Autor:
Xu, Shuang1 (AUTHOR), Ye, Xiao-Ting1 (AUTHOR), Zhang, Dong1 (AUTHOR), Dong, Pu1 (AUTHOR), Wu, Yang-He1 (AUTHOR), Pan, Chen-Wei2 (AUTHOR) panchenwei106@163.com
Publikováno v:
BMC Infectious Diseases. 4, Vol. 24 Issue 1, p1-7. 7p.
Autor:
Zhang, Min, Li, Guangdi, Shang, Jia, Pan, Chen, Zhang, Minxiang, Yin, Zhibiao, Xie, Qing, Peng, Yanzhong, Mao, Qing, Xiao, Xinqiang, Jiang, Yongfang, Luo, Kaizhong, Xu, Yun, Ding, Hai, Fan, Wenzhou, Diego, Vidaurre, Pourkarim, Mahmoud Reza, De Clercq, Erik, Wang, Guiqiang, Gong, Guozhong
Publikováno v:
Hepatology International; Mar2020, Vol. 14 Issue 2, p212-224, 13p
Autor:
YEN, Y.‐H.1 (AUTHOR), HUNG, C.‐H.1 (AUTHOR), HU, T.‐H.1 (AUTHOR), CHEN, C.‐H.1,2 (AUTHOR), WU, C.‐M.1 (AUTHOR), WANG, J.‐H.1 (AUTHOR), LU, S.‐N.1 (AUTHOR), LEE, C.‐M.1,2,3 (AUTHOR)
Publikováno v:
Alimentary Pharmacology & Therapeutics. Jan2008, Vol. 27 Issue 1, p72-79. 8p. 1 Diagram, 3 Charts.
Autor:
Poynard, Thierry1 tpoynard@teaser.fr, Bruix, Jordi2, Schiff, Eugene R.3, Diago, Moises4, Berg, Thomas5, Moreno-Otero, Ricardo6, Lyra, Andre C.7, Carrilho, Flair8, Griffel, Louis H.9, Boparai, Navdeep1,9, Jiang, Ruiyun9, Burroughs, Margaret9, Brass, Clifford A.9, Albrecht, Janice K.9
Publikováno v:
Journal of Hepatology. Mar2013, Vol. 58 Issue 3, p452-459. 8p.
Autor:
Miyase S, Haraoka K, Ouchida Y, Morishita Y, Fujiyama S, Miyase, Shiho, Haraoka, Katsuki, Ouchida, Yoshihiro, Morishita, Yuko, Fujiyama, Shigetoshi
Publikováno v:
Journal of Gastroenterology; Sep2012, Vol. 47 Issue 9, p1014-1021, 8p
Autor:
Huang, Yun1 (AUTHOR), Li, Xiangyong2 (AUTHOR), Zheng, Xiaoyan2 (AUTHOR), Tian, Xiaolu3 (AUTHOR), Yu, Mingxue2 (AUTHOR), Sha, Liuping2 (AUTHOR), Liu, Yinhui4 (AUTHOR), Chong, Yutian2 (AUTHOR), Hao, Yuantao1 (AUTHOR) haoyt@mail.sysu.edu.cn, You, Xu5 (AUTHOR) maja_1983@126.com
Publikováno v:
Journal of Viral Hepatitis. Dec2020, Vol. 27 Issue 12, p1326-1337. 12p.